Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Can the lack of fibrillar form of alpha-synuclein in Lewy bodies be explained by its catalytic activity?

Mathematical Biosciences(2021)10.1016/j.mbs.2021.108754Source: DataRank Database

Can the lack of fibrillar form of alpha-synuclein in Lewy bodies be explained by its catalytic activity? is a research paper published in Mathematical Biosciences (2021). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.42)OA: greenTopics (28)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Andrey V. Kuznetsov ORCID,Ivan A. Kuznetsov ORCID

Live enrichment

PubMed:34890628 PMC:PMC8882444 OpenAlex:https://openalex.org/W4220801852

National Science Foundation

Grant: CBET-2042834

National Institute of Mental Health

Grant: F30 MH122076-01

NIMH NIH HHS

Grant: F30 MH122076

National Institutes of Health

Israel National Road Safety Authority

Alexander von Humboldt-Stiftung

FWCI

0.42

Citation Percentile

0.7%

Citation Trend

2022

2024

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8882444

publisherhttps://api.elsevier.com/content/article/PII:S0025556421001553?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0025556421001553?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.mbs.2021.108754

Fields of Study

Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatmentsNeurological disorders and treatmentsBrainHumansLewy BodiesNeuronsParkinson Diseasealpha-Synuclein

MeSH Terms

BrainHumansNeuronsParkinson DiseaseLewy Bodiesalpha-Synuclein

Keywords

Alpha-synucleinAlpha (finance)NeuroscienceParkinson's diseasePsychologyMedicineInternal medicineDevelopmental psychologyDiseaseNeuronAxonParkinson’s DiseaseMathematical Modeling